Hyperoside Inhibits Endometrial Fibrosis and Inflammation by Targeting TGF-β/Smad3 Signaling in Intrauterine Adhesion Rats

Zhengyan Zhu,Yu Song,Xuemei Chen,Huan Huang,Yuanping Xu,Lin Zhao
DOI: https://doi.org/10.1007/s43450-022-00283-5
2022-12-13
Revista Brasileira de Farmacognosia
Abstract:Intrauterine adhesion is a disorder of endometrial fibrosis which greatly threatens the health and life of women. Hyperoside is a flavonoid glycoside that plays a significant part in multiple disorders. However, the role of hyperoside in intrauterine adhesion remains obscure. Thirty-two female Sprague Dawley rats were divided into four groups with or without treatment of hyperoside, among which two groups were induced by dual injury to induce intrauterine adhesion. Masson staining was used for the histopathological analysis of rat uterine tissues. Western blotting was used for protein expression assessment of endometrial fibrosis markers and the TGF-β / Smad3 signaling-associated markers. Enzyme-linked immunosorbent assay and reverse transcription quantitative polymerase chain reaction were utilized to evaluate the expression of proinflammatory factors in uterine tissues. Hyperoside treatment alleviated endometrial fibrosis and inflammatory response in uterine tissues of rats. Hyperoside repressed the activation of the TGF-β / Smad3 signaling pathway. Hyperoside attenuates endometrial fibrosis and inflammation in an intrauterine adhesion rat model by inactivating the TGF-β / Smad3 signaling.
What problem does this paper attempt to address?